Long-term follow-up cohort study of systemic lupus erythematosus

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021838

Enrollment

Unknown

Registered

2019-03-12

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

systemic lupus erythematosus

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years old, male and female; 2. Can and willing to sign informed consent; 3. Meet the diagnostic criteria for systemic lupus erythematosus; 4. Lupus nephritis.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
classes of lupus nephritis;SLEDAI score;cretinine clearance;anti-ds-DNA;serum C3 levels;serum albumin level;serum creatinine;24-hour urine protein;serum C4 levels;Urine routine;Clinical manifestation;Prognosis;	—

Secondary

Measure	Time frame
complication;Adverse event;Other relevant laboratory indicators;	—

Countries

China

Contacts

Public ContactZhang Bo

The First Affiliated Hospital, Nanjing Medical University, Jiangsu Provincial Hospital

zhangbo@jsph.org.cn+86 13705170907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026